Evidence map›Paper›PMID 28600575›Full record

ArticleScientific reports2017

Altered humoral immunity to mycobacterial antigens in Japanese patients affected by inflammatory demyelinating diseases of the central nervous system.

Davide Cossu, Kazumasa Yokoyama, Yuji Tomizawa, Eiichi Momotani, Nobutaka Hattori

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Autoimmune Diseases and Mycobacterial Infection.Diseases (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Life (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Antibody response to homologous epitopes of Epstein-Barr virus,Journal of translational autoimmunity · 2020
    Article
  12. Immune-mediated genesis of multiple sclerosis.Journal of translational autoimmunity · 2020
    Review
  13. PtpA and PknG Proteins Secreted byJournal of inflammation research · 2019
    Article
  14. Article
  15. Bacteria-Host Interactions in Multiple Sclerosis.Frontiers in microbiology · 2018
    Review
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Davide CossuJuntendo University School of Medicine, Department of Neurology, Tokyo, 113-8421, Japan.
Kazumasa YokoyamaJuntendo University School of Medicine, Department of Neurology, Tokyo, 113-8421, Japan. kazumasa@juntendo.ac.jp.
Yuji TomizawaJuntendo University School of Medicine, Department of Neurology, Tokyo, 113-8421, Japan.
Eiichi MomotaniTohto College of Health Sciences, Department of Human-care, Saitama, 366-0052, Japan.
Nobutaka HattoriJuntendo University School of Medicine, Department of Neurology, Tokyo, 113-8421, Japan.
Juntendo University · JPTohto College of Health Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium avium subsp. paratuberculosis (MAP) and Mycobacterium bovis (BCG) have been associated to several human autoimmune diseases such as multiple sclerosis (MS), but there are conflicting evidence on the issue. The objective of this study is to evaluate their role in Japanese patients affected by inflammatory demyelinating disorders of the central nervous system (IDDs). A total of 97 IDDs subjects including 51 MS and 46 neuromyelitis optica spectrum disorder (NMOSD) patients, and 34 healthy controls (HCs) were tested for the detection of IgG, IgM and IgA against mycobacterial antigens by indirect ELISA. The levels of anti-MAP IgG were higher in MS patients compared to NMOSD patients (AUC = 0.59, p = 0.02) and HCs (AUC = 0.67, p = 0.01), and the anti-MAP antibodies were more prevalent in MS patients treated with interferon-beta (OR = 11.9; p = 0.004). Anti-BCG IgG antibodies were detected in 8% of MS, 32% of NMOSD and 18% of HCs, the difference between MS and NMOSD groups was statistically significant (AUC = 0.66, p = 0.005). Competition experiments showed that nonspecific IgM were elicited by common mycobacterial antigens. Our study provided further evidence for a possible association between MAP and MS, while BCG vaccination seemed to be inversely related to the risk of developing MS.

Indexed as

Immunity, HumoralAdultAntibodiesBCG VaccineCentral Nervous System DiseasesFemaleHumansImmunoglobulin AImmunoglobulin GImmunoglobulin MMaleMiddle AgedMycobacterium aviumMycobacterium bovisNeuromyelitis OpticaAntibodiesBCG VaccineImmunoglobulin AImmunoglobulin GImmunoglobulin M

Identifiers

PMID28600575
PMCPMC5466620
OpenAlexW2623637025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.